✦ LIBER ✦

Cystic fibrosis-associated liver disease

✍ Scribed by Ulrike Herrmann; Gerd Dockter; Frank Lammert

Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 329 KB
Volume: 24
Category: Article
ISSN: 1521-6918
DOI: 10.1016/j.bpg.2010.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Noncirrhotic presinusoidal portal hypert

Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis–associated liver disease

✍ Peter Witters; Louis Libbrecht; Tania Roskams; Kris De Boeck; Lieven Dupont; Mar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

Natural history of liver disease in cyst

Natural history of liver disease in cystic fibrosis

✍ Anders Lindblad; Hans Glaumann; Birgitta Strandvik 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Ursodeoxycholic acid therapy in cystic f

Ursodeoxycholic acid therapy in cystic fibrosis—associated liver disease: A dose-response study

✍ Carla Colombo; Andrea Crosignani; Marisa Assaisso; Pier Maria Battezzati; Mauro 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

Previous studies from our groups have demonstrated improvements in biochemical markers of liver function when cystic fibrosis patients with associated liver disease were administered oral ursodeoxycholic acid. The magnitude of the response was somewhat less than that found when comparable doses (10

Ursodeoxycholic acid for liver disease a

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial

✍ C Colombo; P M Battezzati; M Podda; N Bettinardi; A Giunta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

AND THE ITALIAN GROUP FOR THE STUDY OF URSODEOXYCHOLIC ACID IN CYSTIC FIBROSIS\* ment. Thus, we concluded that UDCA administration im-Liver disease is increasingly recognized as a major proves clinical and biochemical parameters in CF pacause of morbidity in cystic fibrosis (CF). Preliminary tients

Noninvasive assessment of cystic fibrosi

Noninvasive assessment of cystic fibrosis–associated liver disease with acoustic radiation force impulse imaging

✍ Melania Manco; Cristina Lo Zupone; Alessandro Latini; Vincenzina Lucidi; Lidia M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

Liver involvement in cystic fibrosis

✍ Catherine Brigman; Andrew Feranchak 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 993 KB